Protective Effect of Acetyl-L-Carnitine Against Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats. 2016

Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
Department of Pediatrics, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. Electronic address: haticeadiguzel@hotmail.com.

Anthracyclines are one of the most preferred agents in practical pediatric oncology despite their dose-dependent cardiotoxic effects. The aim of this study was to investigate whether or not acetyl-L-carnitine (ALCAR) has protective effects on doxorubicin (DOX)-induced cardiotoxicity. Wistar rats were divided into four groups; control, DOX, ALCAR and ALCAR+DOX. Rats in the first group were given saline on study days, whereas those in the second group were given a single dose of DOX on the 5th day and saline on the other days. Rats in the third group were given ALCAR and those in the fourth group were given ALCAR on study days but also given only a single dose of DOX on the fifth day of the study. Ejection fractions (EF) were measured by echocardiography before and after drug administration. Heart tissues were evaluated by light and electron microscopy. Apoptotic cells were determined with TUNEL and caspase-3 staining. DOX significantly decreased the EF values, whereas ALCAR did not. Cardiac functions were higher in the ALCAR+DOX group when compared to the DOX group. DOX administration caused a cardiac injury not only functionally, but also structurally, whereas ALCAR prevented it. ALCAR has a capacity of preventing DOX-induced cardiac injury at both functional and structural levels.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000108 Acetylcarnitine An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS. Acetyl Carnitine,Medosan,Acetyl-L-Carnitine,Acetylcarnitine, (R)-Isomer,Alcar,Branigen,Levocarnitine Acetyl,Acetyl L Carnitine,Carnitine, Acetyl
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
July 2019, Human & experimental toxicology,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
August 2020, The Journal of international medical research,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
April 2020, Canadian journal of physiology and pharmacology,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
October 2020, Journal of ethnopharmacology,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
October 2023, Biomedicines,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
February 2022, Toxicology mechanisms and methods,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
April 2014, European journal of pharmacology,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
December 2005, Phytotherapy research : PTR,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
August 2012, Journal of medicinal food,
Hatice Adiguzel Dundar, and Muge Kiray, and Mustafa Kir, and Efsun Kolatan, and Alper Bagriyanik, and Zekiye Altun, and Safiye Aktas, and Hulya Ellidokuz, and Osman Yilmaz, and Kamer Mutafoglu, and Nur Olgun
April 2011, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!